RE: Thermo-Fisher valued $200B+ behind VRCI. Mcap should be £60-100m9 Jan 2026 15:04
We should all be extremely excited having now onboarded over 30 transplant centres, up from 10 in 2024.
We know they've gone from 10 onboarded transplant centres to now over 30.
VRCI make $2,650 per Tutivia test + licening revenue from Thermo-Fisher.
334 Tutivia tests ordered for the whole of FY 2024.
H1 2025 / Q1+ Q2 = 591 Tutivia™ tests ordered with about 10-15 transplant centres onboarded.
591 tests x $2650 = $1,566,150
H1 2025 licencing revenue = $750,000.
Q3 2025 286 tests ordered, as per investor presentation, with about 10-15 transplant centre onboarded.
286 x $2,650 = $757,900
Q4 2025, 20 centres onoboarded and let's be conservative and say 300 tests.
300 x $2,650 = $795,000 revenue.
H2 2025 licening revenue, let's be conservative and say $500,000.
Combine all of that above and you get = $4.3mil or £3.2m.
Revenue target comfortably achieved and beaten in this scenario.
That's all with most of the year at just about 10-15 centres onboarded.